Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-054974
Filing Date
2025-05-30
Accepted
2025-05-30 17:05:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2511065-6_424b5.htm 424B5 1033223
2 GRAPHIC lg_adagene-4clr.jpg GRAPHIC 7411
3 GRAPHIC fc_corporate-bw.jpg GRAPHIC 43340
  Complete submission text file 0001104659-25-054974.txt   1101161
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-287161 | Film No.: 251012042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)